Whole-Brain Atrophy Rate and Cognitive Decline: Longitudinal MR Study of Memory Clinic Patients

Radiology ◽  
2008 ◽  
Vol 248 (2) ◽  
pp. 590-598 ◽  
Author(s):  
Jasper D. Sluimer ◽  
Wiesje M. van der Flier ◽  
Giorgos B. Karas ◽  
Nick C. Fox ◽  
Philip Scheltens ◽  
...  
2010 ◽  
Vol 31 (5) ◽  
pp. 758-764 ◽  
Author(s):  
Jasper D. Sluimer ◽  
Femke H. Bouwman ◽  
Hugo Vrenken ◽  
Marinus A. Blankenstein ◽  
Frederik Barkhof ◽  
...  

2008 ◽  
Vol 4 ◽  
pp. T64-T64
Author(s):  
Wiesje M. van der Flier ◽  
Jasper Sluimer ◽  
Femke Bouwman ◽  
Hugo Vrenken ◽  
Marinus A. Blankenstein ◽  
...  

Neurology ◽  
2008 ◽  
Vol 70 (Issue 19, Part 2) ◽  
pp. 1836-1841 ◽  
Author(s):  
J. D. Sluimer ◽  
H. Vrenken ◽  
M. A. Blankenstein ◽  
N. C. Fox ◽  
P. Scheltens ◽  
...  

2010 ◽  
Vol 31 (9) ◽  
pp. 1601-1605 ◽  
Author(s):  
Gabriela Spulber ◽  
Eini Niskanen ◽  
Stuart MacDonald ◽  
Oded Smilovici ◽  
Kewei Chen ◽  
...  

Author(s):  
Y. Wu ◽  
A. D. Smith ◽  
H. Refsum ◽  
Timothy Kwok

Abstract Background and Objectives A randomized placebo-controlled trial found a significant negative interaction between aspirin and B vitamins in cognitive functioning in older people with mild cognitive impairment (MCI). To validate this finding, we pooled data of this trial with that of a similar B-vitamin trial (VITACOG) to examine the effectiveness of B vitamins and their interactions with aspirin in improving global cognitive functioning and slowing brain atrophy in older people with MCI. Design Pooled post-hoc analyses of two randomized placebo-controlled trials. Participants In total, 545 older people with MCI were included in the study. Intervention Placebo or B-vitamin supplements (vitamin B12, folic acid with or without vitamin B6) for 24 months. Measurements The primary outcome was the Clinical Dementia Rating scale-global score (CDR-global). The secondary outcomes were CDR-sum of box score (CDR-SOB), memory Z-score, executive function Z-score, and whole brain atrophy rate. Results 71 (26.2%) and 83 (30.3%) subjects in the active and placebo group respectively were aspirin users. Overall, B vitamins reduced whole brain atrophy rate significantly (P = 0.003), but did not have significant effect on CDR-global, CDR-SOB, memory and executive function. Aspirin use had significant negative interaction effects on B vitamins in CDR-global and CDR-SOB (Beta = 0.993, P = 0.038, and Beta = 0.583, P = 0.009, respectively), but not in memory or executive function Z-scores. Among aspirin non-users, B-vitamin group subjects had more favourable changes in CDR-global and CDR-SOB (P = 0.019 and 0.057, respectively). B vitamins significantly slowed brain atrophy in aspirin non-users (P = 0.001), but not in aspirin users, though the interaction term was not significant (Beta = 0.192, P = 0.276). Conclusion In older people with MCI, B vitamins had significantly favourable effects on global cognitive functioning and whole brain atrophy rate in those who were not taking aspirin, but not in aspirin users.


2008 ◽  
Vol 4 ◽  
pp. T118-T118
Author(s):  
Majon Muller ◽  
Auke P.A. Appelman ◽  
Yolanda van der Graaf ◽  
Willem P.Th.M. Mali ◽  
Mirjam I. Geerlings

2008 ◽  
Vol 4 ◽  
pp. T25-T25
Author(s):  
Majon Muller ◽  
Auke P.A. Appelman ◽  
Yolanda van der Graaf ◽  
Willem P. Th M. Mali ◽  
Mirjam I. Geerlings

Radiology ◽  
2003 ◽  
Vol 229 (3) ◽  
pp. 691-696 ◽  
Author(s):  
Henry Rusinek ◽  
Susan De Santi ◽  
Dina Frid ◽  
Wai-Hon Tsui ◽  
Chaim Y. Tarshish ◽  
...  

2008 ◽  
Vol 4 ◽  
pp. T547-T547
Author(s):  
Wiesje M. Van der Flier ◽  
Jasper Sluimer ◽  
Femke H. Bouwman ◽  
Hugo Vrenken ◽  
Marinus A. Blankenstein ◽  
...  

2014 ◽  
Vol 35 (1) ◽  
pp. 35-41 ◽  
Author(s):  
Minke Kooistra ◽  
Mirjam I. Geerlings ◽  
Yolanda van der Graaf ◽  
Willem P.T.M. Mali ◽  
Koen L. Vincken ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document